No abstract available
MeSH terms
-
Cost-Benefit Analysis
-
Decision Making
-
Hospitalization / economics
-
Humans
-
Immunoglobulins, Intravenous / administration & dosage*
-
Immunoglobulins, Intravenous / economics
-
Infant
-
Infant, Newborn
-
Infant, Premature
-
Infant, Premature, Diseases / economics
-
Infant, Premature, Diseases / prevention & control*
-
Practice Guidelines as Topic
-
Respiratory Syncytial Virus Infections / economics
-
Respiratory Syncytial Virus Infections / prevention & control*
-
Respiratory Syncytial Viruses / immunology*
-
Risk
Substances
-
Immunoglobulins, Intravenous
-
respiratory syncytial virus immune globulin intravenous